TrialCancer science2012

Aurora-A activation, correlated with hypoxia-inducible factor-1α, promotes radiochemoresistance and predicts poor outcome for nasopharyngeal carcinoma.

Xiang-Bo Wan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.